Lakshmi Ramachandran

Lakshmi Ramachandran

Auto-generated profile, based on publicly available information

Lakshmi Ramachandran

Department of Periodontics and Implantology, SRM Dental College, Ramapuram, Chennai, India

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
Jane tony BelindaJane tony Belinda
Jane tony Belinda
HPHARINATH PARTHASARATHY
HARINATH PARTHASARATHY
ATAnupama Tadepalli
Anupama Tadepalli
DPDEEPA PONNAIYAN
DEEPA PONNAIYAN
AAAhmed Alamoudi
Ahmed Alamoudi
Shankargouda PatilShankargouda Patil
Shankargouda Patil
Guided bone regeneration (GBR) is a reliable technique used to treat ridge deficiencies prior or during implant placement. Injectable-platelet rich fibrin (i-PRF) laced with a bone substitute (sticky bone) has heralded the way for advancing the outcomes of bone regeneration. This study evaluated the efficacy of sticky bone in horizontal ridge augmentation with and without collagen membrane. A total of 20 partially edentulous patients (Group-I n = 10; Group-II n = 10) that indicated GBR were included, and the surgical procedure was carried out. In Group-I, the sticky bone and collagen membrane were placed in ridge-deficient sites and Group-II received only sticky bone. At the end of 6 months, 20 patients (Group-I (n = 10); Group-II (n = 10)) completed the follow-up period. A CBCT examination was performed to assess changes in the horizontal ridge width (HRW) and vertical bone height (VBH). A statistically significant increase in HRW (p < 0.05) was observed in both groups with mean gains of 1.35 mm, 1.55 mm, and 1.93 mm at three levels (crest, 3 mm, and 6 mm) in Group-I and 2.7 mm, 2.8 mm, and 2.6 mm at three levels in Group-II. The intergroup comparison revealed statistical significance (p < 0.05) with respect to HRW and KTW (Keratinised tissue width) gains of 0.775 at the 6-month follow-up. Sticky-bone (Xenogenic-bone graft + i-PRF) served as a promising biomaterial in achieving better horizontal bone width gain.

16 August 2023 in Cureus
Verified
Journal Article
Open access
PDF file
PCPriyanka Cholan
Priyanka Cholan
LRLakshmi Ramachandran
Lakshmi Ramachandran
SUSanto G. Umesh
Santo G. Umesh
SPSucharitha P
Sucharitha P
ATAnupama Tadepalli
Anupama Tadepalli
The current advances in digitized data additions, machine learning and computing framework, lead to the swiftly emerging concept of “Artificial Intelligence” (AI), that are developing into areas that were formerly contemplated for human expertise. AI is a relatively rapid paced mechanics wherein the computer technology is tuned to perform human tasks. An auxiliary domain of AI is machine learning (ML), and Deep learning, a subclass of ML technique comprehends multi-layer mathematical operations. AI-based applications have tremendous potential to improve and systematize patient care thereby alleviating dentists from laborious regular tasks, and facilitate personalized, predictive and preventive dentistry. In the dental clinic, AI can execute a variety of easy tasks with greater accuracy, minimal manpower, and with fewer mistakes over human equivalents. These tasks range from appointment scheduling and coordination to helping with clinical evaluation and therapy. Besides, this could assist in the early diagnosis of dental and maxillofacial abnormalities like periodontal ailments, root caries, bony lesions, and facial malformations in addition to automatically identifying and classifying dental restorations on digital radiographs. This brusque narrative review describes the AI-based systems, their respective applications in periodontal diagnosis, the multifarious studies, possible limitations and the predictable future of AI-based dental diagnostics and treatment planning.

1 December 2021 in Journal of Clinical and Diagnostic Research
Verified
Journal Article
Closed access
KSKavitha Selvaprakash
Kavitha Selvaprakash
LRLakshmi Ramachandran
Lakshmi Ramachandran
HPHarinath Parthasarathy
Harinath Parthasarathy
ATAnupama Tadepalli
Anupama Tadepalli
DPDeepa Ponnaiyan
Deepa Ponnaiyan
JKJanani Karthikeyan
Janani Karthikeyan
Introduction: Numerous bioactive grafts have been studied for periodontal defect regeneration of which, beta-Tricalcium Phospate (beta-TCP) is a very promising bone graft. Hyaluronic Acid (HA), an essential component of periodontal ligament matrix plays a pivotal role in tissue growth, repair and remodeling. Aim: To evaluate the efficacy of 0.8% HA as an adjunct to beta-TCP in the treatment of isolated human intrabony defects. Materials and Methods: This comparative clinical study was conducted at the Department of Periodontics, SRM Dental College, Chennai, Tamil Nadu, India, from January 2017 and December 2017 (followed-up to June 2018). The study included 30 intrabony defects from 16 chronic periodontitis patients, 15 of each were randomly assigned into either test/control groups and were reviewed till six months. After phase I therapy regenerative osseous surgery was performed at all the sites. Control sites received beta-TCP bone graft alone and test group received beta-TCP with 0.8% HA. Postsurgical clinical evaluation of Probing Pocket depth (PPD) and Clinical Attachment level (CAL) was done at three and six months, radiographs were repeated at six months to assess the bone fill. Statistical analysis using Statistical Package for the Social Sciences (SPSS) version 22.0 was done, Mann-Whitney U test and Wicloxon-Signed Rank test were used to compare the intergroup and intragroup values respectively. Results: The mean age of the control and test groups were 45.7 and 48.5 years respectively. The PPD was reduced, CAL and bone fill were increased in both groups from baseline, indicating clinical effectiveness. From baseline to six months, the PPD reduction and gain in CAL in the test and control groups were 3.27 +/- 0.18 mm, 3.20 +/- 0.18 mm and 3.07 +/- 0.03 mm, 3.07 +/- 0.08 mm, respectively, which was statistically significant (p-value 0.05) in both clinical and radiographic parameters. Conclusion: Hyaluronic acid as an adjunct to beta-TCP demonstrated only comparable outcomes despite obtaining substantial bone fill and attachment gain.

28 January 2025 in Clinical Advances in Periodontics
Verified
Journal Article
Closed access
KSKavitha Sridhar
Kavitha Sridhar
ATAnupama Tadepalli
Anupama Tadepalli
HPHARINATH PARTHASARATHY
HARINATH PARTHASARATHY
PCPriyanka K. Cholan
Priyanka K. Cholan
LRLakshmi Ramachandran
Lakshmi Ramachandran

12 October 2018 in Journal of Young Pharmacists
Verified
Journal Article
Open access
AKArya Shaji Kumar
Arya Shaji Kumar
RSRaghuveer Prabhu Santhakumara
Raghuveer Prabhu Santhakumara
LRLakshmi Ramachandran
Lakshmi Ramachandran
Pomalidomide, an analogue of thalidomide, developed as a third generation oral immunomodulatory antineoplastic agent used for the management of multiple myeloma refractory to both lenolidomide and bortezomib. It exerts a potential immunomodulatory effect in myeloma cells and T lymphocytes. We report a case of 67 year old male patient undergoing treatment for multiple myeloma presented with fever and cough. He was receiving pomalidomide 4 mg, once daily (OD). After taking pomalidomide he developed fever, cough, breathing difficulty and desaturation. He was tachycardiac and tachypenic, auscultation of chest revealed scattered crepts bilateral, ABG (arterial- blood gas) showed hypoxia and chest X-ray showed hilar opacities. MDCT (Multidetector computed tomography) pulmonology angiogram showed no pulmonary thromboembolism, consolidation involving both the lungs, bilateral minimal left pleural effusion and multiple collapsed thoracic vertebra with lytic lesions in all visualized bones. Most commonly reported hematological complaint was dose dependent bone marrow suppression presented by neutropenia, anemia and thrombocytopenia and most commonly reported non-hematological complaints were fatigue, weakness, constipation and back pain. The drug has been rarely known to cause pulmonary toxicity. We document a case report of pomalidomide related pulmonary toxicity in a patient with Multiple Myeloma and conclude that pulmonary toxicity is a potential adverse reaction of pomalidomide treatment and motivate physicians to remain aware of its clinical presentation. Key words: Immunomodulatory effect, Multiple myeloma, Pomalidomide, Pulmonary toxicity.

6 November 2024 in Clinical Advances in Periodontics
Verified
Journal Article
Closed access
ATAnupama Tadepalli
Anupama Tadepalli
LRLakshmi Ramachandran
Lakshmi Ramachandran
HPHARINATH PARTHASARATHY
HARINATH PARTHASARATHY
PCPriyanka Cholan
Priyanka Cholan
SCSwapna Chekurti
Swapna Chekurti
TPTinu George Peter
Tinu George Peter